全球甲狀腺功能檢測市場規模（按檢測類型、最終用戶、應用、地區、範圍和預測）

甲狀腺功能檢測市場規模及預測

2024 年甲狀腺功能測試市場規模價值為 19.1 億美元，預計到 2031 年將達到 29.4 億美元，2024 年至 2031 年的複合年增長率為 6.10%。

甲狀腺功能測試（TFT）是一種檢查甲狀腺調節新陳代謝和荷爾蒙生成能力的診斷工具。這些檢查可檢測血液樣本中的甲狀腺激素（T3 和 T4）、促甲狀腺激素 (TSH) 和其他甲狀腺相關指標。甲狀腺功能測試對於識別甲狀腺問題（例如甲狀腺功能減退、甲狀腺功能亢進和甲狀腺結節）至關重要。

甲狀腺功能測試在臨床上用於評估甲狀腺健康狀況並追蹤甲狀腺疾病患者的藥物效果。 TFT 也用於新生兒先天性甲狀腺功能低下症的篩檢，以便儘早發現和治療。

展望未來，由於全球甲狀腺疾病盛行率上升、認識和篩檢力度不斷加大以及檢測技術的進步，甲狀腺功能檢測市場展現出良好的成長前景。未來的發展可能集中在提高測試準確性、減少週轉時間以及擴大 TFT 的應用範圍以納入預測指標和即時診斷測試。隨著醫療保健系統向預防醫學和個人化藥物治療方向發展，全面甲狀腺功能檢測的需求可能會上升，從而推動市場成長。

甲狀腺功能檢測市場動態

主要市場驅動因子

甲狀腺疾病發生率不斷上升：這主要是由於甲狀腺功能減退、甲狀腺功能亢進和甲狀腺癌等甲狀腺疾病在全球範圍內的患病率不斷上升。隨著知識和診斷方法的改進，越來越多的人接受甲狀腺疾病檢測，增加了對 TFT 的需求。

診斷技術的進步：TFT 市場的擴張受到技術進步的推動，例如更敏感和更具體的測試、自動化測試平台和即時診斷測試選項。這些進步將提高診斷的準確性，減少週轉時間並為醫療專業人員和患者提供更大的便利。

人口老化和醫療保健意識：日益增長的老齡化人口更容易患甲狀腺疾病，醫療保健意識和篩檢計劃的不斷增加正在推動 TFT 市場的成長。早期檢測和定期監測甲狀腺功能已成為一種常見的程序，從而推動了這些測試的市場需求。

主要問題：

測試結果和解釋的多變性：TFT 可能受到許多變數的影響，包括藥物、疾病和懷孕，導致測試結果的多變性。必須仔細解釋這些數據，考慮到患者的病史和臨床情況，以避免誤診和不適當的治療。

成本限制和報銷問題：TFT 和相關診斷程序的成本對於某些患者和醫療保健系統來說可能過高。各種測試的報銷政策和覆蓋範圍限制為尋求完整甲狀腺健康評估的臨床醫生和患者帶來了財務障礙。

監管和合規課題：TFT 市場的製造商和醫療保健提供者面臨著遵守監管要求和不斷發展的診斷測試程序的課題。確保遵守品質標準、獲得相關認證以及跨多個地點協商監管變化可能是一項耗費資源且耗時的任務。

主要趨勢：

採用先進的測試技術：在 TFT 中，使用高度敏感和特定的檢測、自動化測試平台和分子診斷正變得越來越普遍。這些先進的技術提高了診斷的準確性，縮短了周轉時間，並提高了甲狀腺功能測試的整體效率。

即時診斷檢測 (POCT) 的整合：即時診斷檢測越來越多地被用於測量甲狀腺功能。 POCT 可以進行快速、現場測試，產生即時數據並實現更快地臨床決策。這種趨勢在偏遠和資源有限的環境中以及持續患者監測中特別有用。

重視預防醫學和早期診斷：人們越來越重視甲狀腺疾病的預防醫學和早期發現。由於宣傳力度加大、定期篩檢計畫以及主動健康檢查，越來越多的人接受了甲狀腺功能檢查。這一趨勢源於人們認識到早期發現和治療甲狀腺問題可以顯著改善患者的預後。

目錄

第 1 章簡介

• 市場定義
• 市場區隔
• 研究方法

第 2 章執行摘要

• 主要發現 市場概況 市集亮點

第三章 市場概覽

• 市場規模與成長潛力
• 市場趨勢
• 市場推動因素
• 市場限制
• 市場機會
• 波特五力分析

第 4 章。

• 促甲狀​​腺激素（TSH）測試
• T4（甲狀腺素）測試
• T3（三碘甲狀腺原氨酸）測試
• 甲狀腺抗體檢測

第 5 章 甲狀腺功能檢測市場（依最終用戶劃分）

• 醫院
• 診斷實驗室
• 研究機構

第六章 甲狀腺功能檢測市場（依應用）

• 甲狀腺功能低下症
• 甲狀腺功能亢進
• 甲狀腺結節
• 甲狀腺癌

第 7 章 區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利 亞太地區
• 中國
• 日本
• 印度
• 澳大利亞
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第 8 章 市場動態

• 市場推動因素
• 市場限制
• 市場機會
• COVID-19 對市場的影響

第 9 章 競爭格局

• 大型公司
• 市佔率分析

第十章 公司簡介

• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Roche Diagnostics
• Thermo Fisher Scientific
• Meridian Bioscience, Inc.
• Beckman Coulter Inc.
• Omega Diagnostics Group plc
• Bio-Rad Laboratories, Inc.

第 11 章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第 12 章附錄

• 縮寫列表
• 來源與參考文獻

Thyroid Function Test Market Size And Forecast

Thyroid Function Test Market size was valued at USD 1.91 Billion in 2024 and is projected to reach USD 2.94 Billion by 2031, growing at a CAGR of 6.10% from 2024 to 2031.

Thyroid function tests (TFTs) are diagnostic tools that examine the thyroid gland's ability to regulate metabolism and hormone production. These tests detect thyroid hormones (T3 and T4), thyroid-stimulating hormone (TSH) and other thyroid-related indicators in blood samples. TFTs are essential for identifying thyroid problems such as hypothyroidism, hyperthyroidism and thyroid nodules.

Thyroid function tests are used in clinical diagnostics to assess thyroid health and track medication efficacy in individuals with thyroid disorders. TFTs are also used to screen neonates for congenital hypothyroidism which allows for early detection and management.

Looking ahead, the thyroid function test market exhibits excellent growth prospects owing to rising rates of thyroid illnesses worldwide, increased awareness and screening activities and advancements in testing technology. Future advancements may concentrate on improving test accuracy shortening turnaround times and broadening the application of TFTs to incorporate predictive indicators or point-of-care testing. As healthcare systems promote preventive care and individualized medication, the demand for comprehensive thyroid function testing is likely to rise fueling market growth.

Thyroid Function Test Market Dynamics

The key market dynamics that are shaping the global thyroid function test market include:

Key Market Drivers:

Increasing Incidence of Thyroid Disorders: The increased global prevalence of thyroid problems such as hypothyroidism, hyperthyroidism and thyroid cancer are the major factors. As knowledge and diagnostic methods improve, more people are being checked for thyroid dysfunction which increases demand for TFTs.

Technological Advances in Diagnostic Technologies: TFT market expansion is being driven by technological advancements such as more sensitive and specific assays, automated testing platforms and point-of-care testing choices. These advancements improve diagnostic accuracy, shorten turnaround times and increase convenience for both healthcare personnel and patients.

Aging Population and Healthcare Awareness: The growing aging population which is more susceptible to thyroid diseases together with increased healthcare awareness and screening programs adds to the TFT market's growth. Early detection and regular monitoring of thyroid function have become common procedures driving up market demand for these tests.

Key Challenges:

Variability in Test Findings and Interpretation: TFTs can be affected by a variety of variables including drugs, sickness and pregnancy resulting in variable test findings. To avoid misdiagnosis or inappropriate therapies, these data must be interpreted carefully taking into account the patient's history and clinical situation.

Cost Constraints and Reimbursement Issues: The cost of TFTs and accompanying diagnostic procedures may be prohibitively expensive for some patients and healthcare systems. Reimbursement policies and coverage constraints for various tests differ creating financial hurdles for both clinicians and patients seeking a full thyroid health assessment.

Regulatory and Compliance Challenges: Manufacturers and healthcare providers in the TFT market face challenges in adhering to regulatory requirements and evolving diagnostic testing procedures. Ensuring compliance with quality standards getting relevant certifications and negotiating regulatory changes across multiple locations can be resource-intensive and time-consuming.

Key Trends:

Adoption of Advanced Testing Technologies: In TFTs, the use of extremely sensitive and specific assays, automated testing platforms and molecular diagnostics is becoming increasingly common. These sophisticated technologies improve diagnostic accuracy shorten turnaround times and increase overall efficiency in thyroid function testing.

Integration of Point-of-Care Testing (POCT): Point-of-care testing is increasingly being used to measure thyroid function. POCT provides for rapid, on-site testing resulting in instant data and faster clinical decision-making. This trend is especially useful in remote or resource-limited environments as well as for continuous patient monitoring.

Focus on Preventive Care and Early Diagnosis: There is an increasing emphasis on preventive care and early detection of thyroid diseases. Increased awareness efforts, regular screening programs and proactive health check-ups are encouraging more people to have their thyroid function tested. This tendency stems from the realization that early detection and treatment of thyroid problems can considerably enhance patient outcomes.

Global Thyroid Function Test Market Regional Analysis

Here is a more detailed regional analysis of the global thyroid function test market:

North America:

According to Verified Market Research analyst, North America is expected to dominate the global thyroid function test market.

The region's dominance is due to the widespread availability of thyroid function tests and the presence of trained healthcare professionals. The region's excellent healthcare infrastructure makes diagnostic facilities accessible and healthcare providers are well-trained to deliver and interpret these tests correctly. This accessibility and knowledge help increase the widespread use and reliability of TFTs, resulting in industry development.

Furthermore, the required screening of newborns for congenital hypothyroidism greatly boosts the market. Early discovery through these screens allows for timely care lowering the risk of developmental difficulties linked with thyroid abnormalities. Furthermore, cost-effective technologies for screening thyroid cancer are driving the market. Affordable and efficient diagnostic solutions promote routine screening and early diagnosis, hence improving patient outcomes and expanding the market. These factors together with a strong emphasis on preventive healthcare position North America as a dominant region in the TFT market over the projection period.

Asia Pacific:

Asia-Pacific is the fastest growing region in the thyroid function test (TFT) market over the forecast period owing to rising thyroid health awareness and the incidence of thyroid illnesses. As public health campaigns and educational initiatives raise awareness about the necessity of thyroid function tests, an increasing number of people seek diagnosis and treatment for thyroid-related diseases. This expanding awareness is critical for early detection and management resulting in increased demand for TFTs throughout the region.

Furthermore, the increased frequency of thyroid illnesses such as hypothyroidism, hyperthyroidism and thyroid cancer is a major driver of market expansion in Asia Pacific. Changing lifestyles, dietary patterns and environmental variables all contribute to an increase in the prevalence of these illnesses. As more individuals suffer from thyroid-related health disorders, the demand for accurate and easily accessible diagnostic tests grows supporting the TFT market's rise.

Furthermore, the introduction of many novel tests for monitoring thyroid levels as well as the widespread adoption of important strategic initiatives are increasing market growth. Diagnostic technology advancements give more precise, reliable and cost-effective testing choices making it easier for healthcare providers to detect and manage thyroid diseases. Strategic partnerships, mergers and collaborations among key healthcare sector companies are also increasing the availability and use of advanced TFTs driving the market's rapid expansion in the Asia-Pacific region.

Global Thyroid Function Test Market: Segmentation Analysis

The Global Thyroid Function Test Market is segmented on the basis of Type of Test, End User, Application, and Geography.

Thyroid Function Test Market, By Type of Test

• Thyroid-Stimulating Hormone (TSH) Tests
• T4 (Thyroxine) Tests
• T3 (Triiodothyronine) Tests
• Thyroid Antibody Tests

Based on Type of Test, the market is Thyroid-Stimulating Hormone (TSH) Tests, T4 (Thyroxine) Tests, T3 (Triiodothyronine) Tests and Thyroid Antibody Tests. Thyroid-Stimulating Hormone (TSH) Tests dominate the thyroid function testing industry. TSH tests are critical for detecting and managing thyroid problems because they give a sensitive and accurate picture of thyroid function. They are frequently the first-line tests recommended by healthcare providers making them the most commonly utilized and necessary in clinical practice.

Thyroid Function Test Market, By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes

Based on End User, the market is divided into Hospitals, Diagnostic Laboratories, and Research Institutes. Thyroid function tests (TFTs) are mostly used by hospitals. Their extensive healthcare offerings, large patient volume and availability of advanced diagnostic facilities all contribute to their supremacy. Hospitals are frequently the principal sites for thyroid problem diagnosis, treatment and management assuring a continual need for TFTs in their everyday clinical processes.

Thyroid Function Test Market, By Application

• Hypothyroidism
• Hyperthyroidism
• Thyroid Nodules
• Thyroid Cancer

Based on Application, the market is segmented into Hypothyroidism, Hyperthyroidism, Thyroid Nodules and Thyroid Cancer. Hypothyroidism is the most common application in the thyroid function testing (TFT) market. This dominance is due to its widespread occurrence as well as the need for ongoing monitoring and treatment. Hypothyroidism necessitates frequent TFTs to properly adapt and manage treatment resulting in a continual demand for these tests in clinical settings.

Thyroid Function Test Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Thyroid Function Test Market is classified into North America, Europe, Asia Pacific and the Rest of the world. North America dominates the global thyroid function test (TFT) market due to broad test availability, competent healthcare providers, mandated newborn screening and low-cost cancer diagnostics. Meanwhile, Asia-Pacific is the fastest-growing region due to increased awareness, higher thyroid problem prevalence and advances in diagnostic tools. Strategic actions and public health campaigns drive up demand for TFTs in the Asia Pacific region.

Key Players

• The Global Thyroid Function Test study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Roche Diagnostics, Thermo Fisher Scientific, Meridian Bioscience Inc., Beckman Coulter Inc., Omega Diagnostics Group plc and Bio-Rad Laboratories Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Thyroid Function Test Market Recent Developments
• In February 2021, Abbott Laboratories and Roche Diagnostics recently made waves with a research comparing their thyroid tests for subclinical hypothyroidism. The study discovered that Roche's free thyroxine and TSH assays produced much higher diagnostic results for subclinical hypothyroidism (SCH) than Abbott's thyroid assays.
• In May 2020, Eli Lilly and Company received approval from the U.S. Food and Drug Administration (FDA) for Retevmo, a treatment for Advanced or metastatic RET fusion-positive thyroid cancer, Advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and Metastatic RET fusion-positive non-small cell lung cancer (NSCLC).

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Thyroid Function Test Market, By Type of Test

• Thyroid-Stimulating Hormone (TSH) Tests
• T4 (Thyroxine) Tests
• T3 (Triiodothyronine) Tests
• Thyroid Antibody Tests

5. Thyroid Function Test Market, By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes

6. Thyroid Function Test Market, By Application

• Hypothyroidism
• Hyperthyroidism
• Thyroid Nodules
• Thyroid Cancer

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Roche Diagnostics
• Thermo Fisher Scientific
• Meridian Bioscience, Inc.
• Beckman Coulter Inc.
• Omega Diagnostics Group plc
• Bio-Rad Laboratories, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References